Health Care
Price
$78.27
-0.10%Market Cap
$13.55B
Day High
$79.97
Day Low
$77.69
SOLV's Q1 FY2026 results showed significant earnings deterioration with net income plunging 90.5% YoY to $13M on a 3.0% revenue decline to $2.007B, driven by a sharp 7.5% rise in SG&A expenses and negative operating cash flow of -$189M, though the balance sheet improved materially with long-term debt cut by 41.4% and stockholders' equity up 52.3%.
Key risk: Severe Operating Cash Flow Deterioration
Operating cash flow swung to -$189M in Q1 FY2026 from +$29M a year ago, representing a 751.7% deterioration. If this trend persists, SOLV may face liquidity constraints, particularly given its current ratio of only 1.07x and ongoing capital expenditure needs. The company's decision to repurchase $67M in shares while burning cash operationally adds further pressure.
Other Health Care Technology companies